OrthoPediatrics director Berry retires, CEO Bailey joins board; compensation policy updated

ORTHOPEDIATRICS CORP

Bernie Berry, III retired from board Nov 3, 2021 after 12 years; no disagreement. Granted 2,119 shares and accelerated vesting.
CEO David R. Bailey appointed to fill vacancy, term until 2024; as employee director, no compensation.
Board amended director compensation policy effective Jan 1, 2022: annual stock grant changed to $75,000 value, meeting fees to $18,750/quarter.
Chairperson annual fees increased: Board, Comp, Gov committees to $5,000; Audit Committee chair to $10,000.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bernie Berry, III

Director

KIDS · ORTHOPEDIATRICS CORP

Effective: 2021-11-03
Successor: David R. Bailey
Filed: November 4, 2021, 7:59 PM ET

Effective November 3, 2021, Bernie Berry, III has retired from the Company's Board of Directors after twelve years of service.

Appointed

David R. Bailey

Director

KIDS · ORTHOPEDIATRICS CORP

Effective: 2021-11-03
Filed: November 4, 2021, 7:59 PM ET

The Board has appointed David R. Bailey, the Company’s President and Chief Executive Officer, to fill the vacancy caused by Mr. Berry’s retirement to serve in the Class of Directors whose terms expire at the annual shareholder meeting in 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bernie Berry, III retired as Director at ORTHOPEDIATRICS CORP.

Action: retired
Role: Director

Exact text from the filing

Effective November 3, 2021, Bernie Berry, III has retired from the Company's Board of Directors after twelve years of service.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David R. Bailey was appointed as Director at ORTHOPEDIATRICS CORP.

Action: appointed
Role: Director

Exact text from the filing

The Board has appointed David R. Bailey, the Company’s President and Chief Executive Officer, to fill the vacancy caused by Mr. Berry’s retirement to serve in the Class of Directors whose terms expire at the annual shareholder meeting in 2024.

View on SEC.gov

ORTHOPEDIATRICS CORP filing history →

Source: SEC EDGAR

accession 0001425450-21-000148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.